http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d3fe13f1056e24fbd5c2144319c93f7
Outgoing Links
Predicate | Object |
---|---|
family-name | Schroth |
name | Werner Schroth |
given-name | Werner |
organization-name | Dr. Margarete Fischer‐Bosch Institute of Clinical Pharmacology Stuttgart Germany; University of Tübingen Tübingen Germany 1Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany;; 2Department of Clinical Pharmacology University Tübingen, Tübingen, Germany; Dr. Margarete Fischer‐Bosch‐Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen Germany Dr. Margarete Fischer‐Bosch‐Institute of Clinical Pharmacology Stuttgart and University of Tuebingen Germany Dr. Margarete Fischer‐Bosch-Institute of Clinical Pharmacology Stuttgart Germany; University of Tuebingen Tuebingen Germany Dr Margarete Fischer‐Bosch Institute of Clinical Pharmacology Stuttgart and University Tubingen Germany Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Tuebingen, Germany From the Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, the University Tuebingen, and the Robert Bosch Hospital, Stuttgart; and the Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; and University Tuebingen, Tuebingen, Germany Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University Tübingen, Germany Hiltrud Brauch, PhD, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany, University of Tübingen, Tübingen, Germany, and German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Werner Schroth, PhD and Thomas Mürdter, PhD, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany, and University of Tübingen, Tübingen, Germany; and Matthias Schwab, MD, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology,... Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. werner.schroth@ikp-stuttgart.de. University of Tübingen, Tübingen, Germany. Authors' Affiliations: 1Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University Tübingen, Germany; 2Deutsches Krebsforschungszentrum, Heidelberg, Germany; 3University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; 4David Geffen School of Medicine, University of California at Los Angeles, Division of Hematology and Oncology, Los Angeles; and 5Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany 1Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and; 3University of Tübingen and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376 Stuttgart, Germany. hiltrud.brauch@ikp-stuttgart.de Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; and University Tübingen, Tübingen, Germany Institut für Anorganische Chemie and Wilhelm-Ostwald-Institut für Physikalische und Theoretische Chemie, Universität Leipzig, Johannisallee 29, D-04103 Leipzig, Germany, Kurt-Schwabe-Institut für Mess- und Sensortechnik e.V., D-04720 Ziegra-Knobelsdorf, Germany, Institut für Organische Chemie, Martin-Luther-Universität Halle-Wittenberg Kurt-Mothes-Strasse 2, D 06120 Wittenberg, Germany, and van't Hoff Institute for Molecular Sciences, Universiteit van Amsterdam, Nieuwe Achtergracht 166, 1018 WV Amsterdam... Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University Tuebingen, Tuebingen, Germany |
Incoming Links
Total number of triples: 72.